The influence of local antichlamydial antibody on the acquisition and persistence of human ocular chlamydial infection: IgG antibodies are not protective

Epidemiology and Infection

Volumn 111, Issue 2, 1993, Pages 315-324

  Bailey, R L ^a   Kajbaf, M ^b   Whittle, H C ^c   Ward, M E ^b   Mabey, D C W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^c MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ANTIGEN; BACTERIUM ANTIBODY; ERYTHROMYCIN; GLYCOLIPID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; TETRACYCLINE;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CHLAMYDIA TRACHOMATIS; ENZYME IMMUNOASSAY; FEMALE; GAMBIA; HUMAN; HUMAN TISSUE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; RISK FACTOR; SEROTYPE; TOPICAL DRUG ADMINISTRATION; TRACHOMA; VACCINE PRODUCTION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; CHLAMYDIA TRACHOMATIS; CONJUNCTIVA; GAMBIA; HUMAN; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; PREVALENCE; RECURRENCE; REGRESSION ANALYSIS; SUPPORT, NON-U.S. GOV'T; TEARS; TRACHOMA;

EID: 0027438181     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268800057022     Document Type: Article

References (27)

1. Dawson CR, Jones BR, Tarizzo ML. A guide to trachoma control. Geneva: World Health Organisation, 1981.
2. Treharne JD. The community epidemiology of trachoma. Rev Infect Dis 1985; 7: 760–4.
3. Mabey DCW, Robertson JN, Ward ME. Detection of Chlamydia trachomatis by enzyme immunoassay in patients with trachoma. Lancet 1987; ii: 1491–2.
4. Wang S-P, Grayston JT, Alexander ER. Trachoma vaccine studies in monkeys. Am J Ophthalmol 1967; 63: 1615–30.
5. Murray ES, Charbonnet LT, MacDonald AB. Immunity to chlamydial infections of the eye. I. The role of circulatory and secretory antibodies in resistance to reinfection with guinea pig conjunctivitis. J Immunol 1973; 110: 1518–25.
6. Orenstein NS, Mull JD, Thompson SE. Immunity to chlamydial infections of the eye. V. Passive transfer of antitrachoma antibodies to owl monkeys. Infect Immun 1973; 7: 600–3.
7. Bernkopf H, Orfila J, Maythar B. Fluorescent antibodies in the fluid of the conjunctival sac of trachoma patients. Nature 1966; 209: 725–6.
8. Nichols RL, Oertley RE, Fraser CEO, MacDonald AB, McComb DE. Immunity to chlamydial infections of the eye. VI. Homologous neutralisation of trachoma infectivity for the owl monkey conjunctivae by eye secretions from humans with trachoma. J Infect Dis 1973; 127: 429–32.
9. Barenfanger J, MacDonald AB. The role of immunoglobulin in the neutralisation of trachoma infectivity. J Immunol 1974; 113: 1607–17.
10. McComb DE, Nichols RL. Antibody type specificity to trachoma in eye secretions of Saudi Arab children. Infect Immun 1970; 2: 65–8.
11. Collier LH, Sowa J, Sowa S. The serum and conjunctival antibody response to trachoma in Gambian children. J Hyg 1972; 70: 727–40.
12. Treharne JD, Dwyer RStC, Darougar S, Jones BR, Daghfous T. Antichlamydial antibody in tears and sera, and serotypes of Chlamydia trachomatis isolated from schoolchildren in southern Tunisia. Br J Ophthalmol 1978; 62: 509–15.
13. Thompson B. Marriage, childbirth and early childhood in a Gambian village: a sociomedical study. PhD thesis, University of Aberdeen, 1965.
14. McGregor IA. Health and communicable disease in a rural African environment. Oikos 1976; 27: 180–92.
15. Ward ME, Bailey R, Lesley A, Kajbaf M, Robertson J, Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis 1990; Suppl 69: 137–48.
16. Hathaway A, Peters JH. Characterisation of antibodies to trachoma in human eye secretions. In: Nichols RL, ed. Trachoma and related disorders. Amsterdam: Excerpta Medica; 1971: 260–8.
17. Brunham RC, Kuo C-C, Cles L, Holmes KK. Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix. Infect Immun 1983; 39: 1491–4.
18. Mabey DCW, Bailey RL, Ward ME, Whittle HC. A longitudinal study of trachoma in a Gambian village. Implications concerning the pathogenesis of chlamydial infection. Epidemiol Infect 1992; 108: 343–51.
19. Mabey DCW, Forsey T, Treharne JD. Serotypes of Chlamydia trachomatis in The Gambia. Lancet 1987; ii: 452.
20. Hayes LJ, Bailey RL, Mabey DCW, Genotyping of Chlamydia trachomatis from a trachoma-endemic village in The Gambia by a nested polymerase chain reaction: identification of strain variants. J Infect Dis 1992; 166: 1173–7.
21. Woolridge RL, Grayston JT, Chang IH, Cheng KH, Yang CY, Neave C. Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol 1967; 63: 1645–50.
22. Griffiss JM, Bertram MA. Immunoepidemiology of meningococcal disease in military recruits. II. Blocking of serum bactericidal activity by circulating IgA early in the course of disease. J Infect Dis 1977; 136: 733–9.
23. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibody dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue haemorrhagic fever. Am J Trop Med Hyg 1989; 40: 444–51.
24. Su H, Spangrude GJ, Caldwell HD. Expression of FegammaIIl on HeLa 229 cells: possible effect on in vitro neutralisation of Chlamydia trachomatis. Infect Immun 1991; 59: 3811–14.
25. Peterson EM, Cheng X, Pal S, De la Maza LM. Effects of antibody isotype and host cell type on in vitro neutralisation of Chlamydia trachomatis. Infect Immun 1993; 61: 498–503.
26. Mabey DCW, Bailey RL, Dunn D, Jones D, Williams JHD, Whittle HC, Ward ME. Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease. J Clin Pathol 1991; 44: 285–9.
27. Mabey DCW, Bailey RL, Hutin YJF. The epidemiology and pathogenesis of trachoma. Rev Med Micro 1992; 3: 112–19.